527 related articles for article (PubMed ID: 33586060)
21. Extracellular vesicles remodel tumor environment for cancer immunotherapy.
Yue M; Hu S; Sun H; Tuo B; Jia B; Chen C; Wang W; Liu J; Liu Y; Sun Z; Hu J
Mol Cancer; 2023 Dec; 22(1):203. PubMed ID: 38087360
[TBL] [Abstract][Full Text] [Related]
22. Tumor-Derived Exosomes (TEX) and Their Role in Immuno-Oncology.
Whiteside TL; Diergaarde B; Hong CS
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207762
[TBL] [Abstract][Full Text] [Related]
23. Isolation and characterization of exosomes for cancer research.
Zhu L; Sun HT; Wang S; Huang SL; Zheng Y; Wang CQ; Hu BY; Qin W; Zou TT; Fu Y; Shen XT; Zhu WW; Geng Y; Lu L; Jia HL; Qin LX; Dong QZ
J Hematol Oncol; 2020 Nov; 13(1):152. PubMed ID: 33168028
[TBL] [Abstract][Full Text] [Related]
24. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.
Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES
Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474
[TBL] [Abstract][Full Text] [Related]
25. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
[TBL] [Abstract][Full Text] [Related]
26. Exosome-based anticancer vaccines: From Bench to bedside.
Zhao G; Wang Y; Xing S; Jiang Y; Ding J; Cai Y; Ma P; Miao H; Fang Y; Jiang N; Cui D; Yu Y; Tang Q; Wang S; Li N
Cancer Lett; 2024 Jul; 595():216989. PubMed ID: 38825162
[TBL] [Abstract][Full Text] [Related]
27. New insights into exosome mediated tumor-immune escape: Clinical perspectives and therapeutic strategies.
Pathania AS; Prathipati P; Challagundla KB
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188624. PubMed ID: 34487817
[TBL] [Abstract][Full Text] [Related]
28. Tumor-derived exosomes in the PD-1/PD-L1 axis: Significant regulators as well as promising clinical targets.
Liang B; Hu X; Ding Y; Liu M
J Cell Physiol; 2021 Jun; 236(6):4138-4151. PubMed ID: 33275291
[TBL] [Abstract][Full Text] [Related]
29. The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer.
Hofmann L; Ludwig S; Vahl JM; Brunner C; Hoffmann TK; Theodoraki MN
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517240
[TBL] [Abstract][Full Text] [Related]
30. Application of extracellular vesicles in the diagnosis and treatment of prostate cancer: Implications for clinical practice.
Oey O; Ghaffari M; Li JJ; Hosseini-Beheshti E
Crit Rev Oncol Hematol; 2021 Nov; 167():103495. PubMed ID: 34655743
[TBL] [Abstract][Full Text] [Related]
31. Recent Advances in Experimental Models of Breast Cancer Exosome Secretion, Characterization and Function.
Pelissier Vatter FA; Lucotti S; Zhang H
J Mammary Gland Biol Neoplasia; 2020 Dec; 25(4):305-317. PubMed ID: 33351162
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy.
Brozos-Vázquez EM; Díaz-Peña R; García-González J; León-Mateos L; Mondelo-Macía P; Peña-Chilet M; López-López R
Cancer Immunol Immunother; 2021 May; 70(5):1177-1188. PubMed ID: 33113004
[TBL] [Abstract][Full Text] [Related]
33. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
34. Exosomes as a Multicomponent Biomarker Platform in Cancer.
LeBleu VS; Kalluri R
Trends Cancer; 2020 Sep; 6(9):767-774. PubMed ID: 32307267
[TBL] [Abstract][Full Text] [Related]
35. Exosome-based liquid biopsies in cancer: opportunities and challenges.
Yu W; Hurley J; Roberts D; Chakrabortty SK; Enderle D; Noerholm M; Breakefield XO; Skog JK
Ann Oncol; 2021 Apr; 32(4):466-477. PubMed ID: 33548389
[TBL] [Abstract][Full Text] [Related]
36. Exosomes as A Next-Generation Diagnostic and Therapeutic Tool in Prostate Cancer.
Gaglani S; Gonzalez-Kozlova E; Lundon DJ; Tewari AK; Dogra N; Kyprianou N
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576294
[TBL] [Abstract][Full Text] [Related]
37. The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.
Petitprez F; Meylan M; de Reyniès A; Sautès-Fridman C; Fridman WH
Front Immunol; 2020; 11():784. PubMed ID: 32457745
[TBL] [Abstract][Full Text] [Related]
38. Exosomes: Powerful weapon for cancer nano-immunoengineering.
Pi YN; Xia BR; Jin MZ; Jin WL; Lou G
Biochem Pharmacol; 2021 Apr; 186():114487. PubMed ID: 33647264
[TBL] [Abstract][Full Text] [Related]
39. Exosomes carrying immune checkpoints, a promising therapeutic approach in cancer treatment.
Rasihashemi SZ; Sahrai H; Rezazadeh-Gavgani E; Yazdani Y; Khalaji A; Lotfinejad P
Med Oncol; 2022 Sep; 39(12):183. PubMed ID: 36071295
[TBL] [Abstract][Full Text] [Related]
40. Exosomes as a new frontier of cancer liquid biopsy.
Yu D; Li Y; Wang M; Gu J; Xu W; Cai H; Fang X; Zhang X
Mol Cancer; 2022 Feb; 21(1):56. PubMed ID: 35180868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
